Most Active Options Update: Gilead Sciences (GILD)

Gilead Sciences, Inc. traders are betting on short-term upside

Nov 10, 2014 at 1:48 PM
facebook X logo linkedin

The 20 stocks listed in the table below have attracted the highest total options volume during the past 10 trading days. Names highlighted are new to the list since the last time the study was run, and data is courtesy of Schaeffer's Senior Quantitative Analyst Rocky White. One name of notable interest today is biopharmaceutical concern Gilead Sciences, Inc. (NASDAQ:GILD), as Merck & Co., Inc.'s (NYSE:MRK) loss appears to be GILD's gain.

Most Active Options Table

Gilead Sciences, Inc. is up 1% at $107.47, thanks to ebbing concerns about competition from MRK's hepatitis C treatment. As such, analysts are waxing optimistic on GILD -- maker of blockbuster drug Sovaldi, which proved extremely effective when paired with Achillion Pharmaceuticals Inc's (NASDAQ:ACHN) ACH-3102 -- as they expect the company to maintain the upper hand in the hepatitis C market. In fact, FBR opined that ACHN could emerge as a possible acquisition target for GILD, while Nomura hiked its price target on GILD to $152 from $148 and underscored a "buy" endorsement.

In the options pits, GILD calls are outnumbering puts by a margin of more than 2-to-1, with roughly 28,000 contracts exchanged. Digging deeper, it appears short-term bulls are buying to open the weekly 11/14 110-strike call, where most of the contracts have traded on the ask side, and volume has surpassed open interest.

By purchasing the weekly calls at a volume-weighted average price (VWAP) of $1.12, the buyers expect GILD to climb atop $111.12 (strike plus VWAP) by Friday's close, when the series expires. Should the equity remain south of the strike through the end of the week, the most the buyers will lose is the initial premium paid for the calls.

Longer-term bulls are seemingly buying to open the December 115 call, which is the second most active option so far today. By purchasing the calls at a VWAP of $2.67, the traders expect GILD to muscle north of $117.67 -- in record-high territory -- by the close on Friday, Dec. 19, when back-month options expire. Again, risk is capped at the initial premium paid, should GILD remain beneath the strike through the option's lifetime.

Now is an opportune time to buy Gilead Sciences, Inc.'s (NASDAQ:GILD) short-term options. The stock's Schaeffer's Volatility Index (SVI) of 34% stands higher than just 35% of all other readings from the past year, suggesting the stock's near-term options are attractively priced, historically speaking.


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI